The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Orally Disintegrating Tablet Excipient Market Research Report 2024

Global Orally Disintegrating Tablet Excipient Market Research Report 2024

Publishing Date : Jan, 2024

License Type :
 

Report Code : 1598211

No of Pages : 105

Synopsis
An orally disintegrating tablet or orally dissolving tablet (ODT) is a drug dosage form available for a limited range of over-the-counter (OTC) and prescription medications.An excipient is a pharmacologically inert adhesive substance used to bind the contents of a pill or tablet. This type of tablet separates in the mouth in contact with saliva, making it easy for a person to swallow the tablet without drinking water.
The global Orally Disintegrating Tablet Excipient market was valued at US$ 16650 million in 2023 and is anticipated to reach US$ 21240 million by 2030, witnessing a CAGR of 3.5% during the forecast period 2024-2030.
McePharma (Vivesa holding) was the global greatest company in Orally Disintegrating Tablet Excipient industry, with the revenue market Share of 3% , followed by BASF, JRS Pharma, Roquette, ABF Ingredients, DFE Pharma, Evonik, Merck KGaA, Ashland, Meggle Pharma, Shin-Etsu, Fuji Chemical Industries, Cargill Incorporated, Daicel Corporation, Anhui Sunhere Pharmaceutical.APAC is the largest Orally Disintegrating Tablet Excipient market with about 30% market share. Americas is follower, accounting for about 27% market share.
This report aims to provide a comprehensive presentation of the global market for Orally Disintegrating Tablet Excipient, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Orally Disintegrating Tablet Excipient.
Report Scope
The Orally Disintegrating Tablet Excipient market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Orally Disintegrating Tablet Excipient market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Orally Disintegrating Tablet Excipient manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
BASF
JRS Pharma
Roquette
ABF Ingredients
DFE Pharma
Evonik
Merck KGaA
Ashland
Meggle Pharma
Shin-Etsu
Fuji Chemical Industries
McePharma (Vivesa holding)
Cargill Incorporated
Daicel Corporation
Anhui Sunhere Pharmaceutical
Segment by Type
Binders
Glidents
Diluents
Disintegrants
Others
Segment by Application
Anti-Psychotics Drug
Anti-Epileptics Drug
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Orally Disintegrating Tablet Excipient manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Orally Disintegrating Tablet Excipient in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index
1 Orally Disintegrating Tablet Excipient Market Overview
1.1 Product Overview and Scope of Orally Disintegrating Tablet Excipient
1.2 Orally Disintegrating Tablet Excipient Segment by Type
1.2.1 Global Orally Disintegrating Tablet Excipient Market Value Comparison by Type (2024-2030)
1.2.2 Binders
1.2.3 Glidents
1.2.4 Diluents
1.2.5 Disintegrants
1.2.6 Others
1.3 Orally Disintegrating Tablet Excipient Segment by Application
1.3.1 Global Orally Disintegrating Tablet Excipient Market Value by Application: (2024-2030)
1.3.2 Anti-Psychotics Drug
1.3.3 Anti-Epileptics Drug
1.3.4 Others
1.4 Global Orally Disintegrating Tablet Excipient Market Size Estimates and Forecasts
1.4.1 Global Orally Disintegrating Tablet Excipient Revenue 2019-2030
1.4.2 Global Orally Disintegrating Tablet Excipient Sales 2019-2030
1.4.3 Global Orally Disintegrating Tablet Excipient Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Orally Disintegrating Tablet Excipient Market Competition by Manufacturers
2.1 Global Orally Disintegrating Tablet Excipient Sales Market Share by Manufacturers (2019-2024)
2.2 Global Orally Disintegrating Tablet Excipient Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Orally Disintegrating Tablet Excipient Average Price by Manufacturers (2019-2024)
2.4 Global Orally Disintegrating Tablet Excipient Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Orally Disintegrating Tablet Excipient, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Orally Disintegrating Tablet Excipient, Product Type & Application
2.7 Orally Disintegrating Tablet Excipient Market Competitive Situation and Trends
2.7.1 Orally Disintegrating Tablet Excipient Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Orally Disintegrating Tablet Excipient Players Market Share by Revenue
2.7.3 Global Orally Disintegrating Tablet Excipient Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Orally Disintegrating Tablet Excipient Retrospective Market Scenario by Region
3.1 Global Orally Disintegrating Tablet Excipient Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Orally Disintegrating Tablet Excipient Global Orally Disintegrating Tablet Excipient Sales by Region: 2019-2030
3.2.1 Global Orally Disintegrating Tablet Excipient Sales by Region: 2019-2024
3.2.2 Global Orally Disintegrating Tablet Excipient Sales by Region: 2025-2030
3.3 Global Orally Disintegrating Tablet Excipient Global Orally Disintegrating Tablet Excipient Revenue by Region: 2019-2030
3.3.1 Global Orally Disintegrating Tablet Excipient Revenue by Region: 2019-2024
3.3.2 Global Orally Disintegrating Tablet Excipient Revenue by Region: 2025-2030
3.4 North America Orally Disintegrating Tablet Excipient Market Facts & Figures by Country
3.4.1 North America Orally Disintegrating Tablet Excipient Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Orally Disintegrating Tablet Excipient Sales by Country (2019-2030)
3.4.3 North America Orally Disintegrating Tablet Excipient Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Orally Disintegrating Tablet Excipient Market Facts & Figures by Country
3.5.1 Europe Orally Disintegrating Tablet Excipient Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Orally Disintegrating Tablet Excipient Sales by Country (2019-2030)
3.5.3 Europe Orally Disintegrating Tablet Excipient Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Orally Disintegrating Tablet Excipient Market Facts & Figures by Country
3.6.1 Asia Pacific Orally Disintegrating Tablet Excipient Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Orally Disintegrating Tablet Excipient Sales by Country (2019-2030)
3.6.3 Asia Pacific Orally Disintegrating Tablet Excipient Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Orally Disintegrating Tablet Excipient Market Facts & Figures by Country
3.7.1 Latin America Orally Disintegrating Tablet Excipient Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Orally Disintegrating Tablet Excipient Sales by Country (2019-2030)
3.7.3 Latin America Orally Disintegrating Tablet Excipient Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Orally Disintegrating Tablet Excipient Market Facts & Figures by Country
3.8.1 Middle East and Africa Orally Disintegrating Tablet Excipient Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Orally Disintegrating Tablet Excipient Sales by Country (2019-2030)
3.8.3 Middle East and Africa Orally Disintegrating Tablet Excipient Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Orally Disintegrating Tablet Excipient Sales by Type (2019-2030)
4.1.1 Global Orally Disintegrating Tablet Excipient Sales by Type (2019-2024)
4.1.2 Global Orally Disintegrating Tablet Excipient Sales by Type (2025-2030)
4.1.3 Global Orally Disintegrating Tablet Excipient Sales Market Share by Type (2019-2030)
4.2 Global Orally Disintegrating Tablet Excipient Revenue by Type (2019-2030)
4.2.1 Global Orally Disintegrating Tablet Excipient Revenue by Type (2019-2024)
4.2.2 Global Orally Disintegrating Tablet Excipient Revenue by Type (2025-2030)
4.2.3 Global Orally Disintegrating Tablet Excipient Revenue Market Share by Type (2019-2030)
4.3 Global Orally Disintegrating Tablet Excipient Price by Type (2019-2030)
5 Segment by Application
5.1 Global Orally Disintegrating Tablet Excipient Sales by Application (2019-2030)
5.1.1 Global Orally Disintegrating Tablet Excipient Sales by Application (2019-2024)
5.1.2 Global Orally Disintegrating Tablet Excipient Sales by Application (2025-2030)
5.1.3 Global Orally Disintegrating Tablet Excipient Sales Market Share by Application (2019-2030)
5.2 Global Orally Disintegrating Tablet Excipient Revenue by Application (2019-2030)
5.2.1 Global Orally Disintegrating Tablet Excipient Revenue by Application (2019-2024)
5.2.2 Global Orally Disintegrating Tablet Excipient Revenue by Application (2025-2030)
5.2.3 Global Orally Disintegrating Tablet Excipient Revenue Market Share by Application (2019-2030)
5.3 Global Orally Disintegrating Tablet Excipient Price by Application (2019-2030)
6 Key Companies Profiled
6.1 BASF
6.1.1 BASF Corporation Information
6.1.2 BASF Description and Business Overview
6.1.3 BASF Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2019-2024)
6.1.4 BASF Orally Disintegrating Tablet Excipient Product Portfolio
6.1.5 BASF Recent Developments/Updates
6.2 JRS Pharma
6.2.1 JRS Pharma Corporation Information
6.2.2 JRS Pharma Description and Business Overview
6.2.3 JRS Pharma Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2019-2024)
6.2.4 JRS Pharma Orally Disintegrating Tablet Excipient Product Portfolio
6.2.5 JRS Pharma Recent Developments/Updates
6.3 Roquette
6.3.1 Roquette Corporation Information
6.3.2 Roquette Description and Business Overview
6.3.3 Roquette Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Roquette Orally Disintegrating Tablet Excipient Product Portfolio
6.3.5 Roquette Recent Developments/Updates
6.4 ABF Ingredients
6.4.1 ABF Ingredients Corporation Information
6.4.2 ABF Ingredients Description and Business Overview
6.4.3 ABF Ingredients Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2019-2024)
6.4.4 ABF Ingredients Orally Disintegrating Tablet Excipient Product Portfolio
6.4.5 ABF Ingredients Recent Developments/Updates
6.5 DFE Pharma
6.5.1 DFE Pharma Corporation Information
6.5.2 DFE Pharma Description and Business Overview
6.5.3 DFE Pharma Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2019-2024)
6.5.4 DFE Pharma Orally Disintegrating Tablet Excipient Product Portfolio
6.5.5 DFE Pharma Recent Developments/Updates
6.6 Evonik
6.6.1 Evonik Corporation Information
6.6.2 Evonik Description and Business Overview
6.6.3 Evonik Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Evonik Orally Disintegrating Tablet Excipient Product Portfolio
6.6.5 Evonik Recent Developments/Updates
6.7 Merck KGaA
6.6.1 Merck KGaA Corporation Information
6.6.2 Merck KGaA Description and Business Overview
6.6.3 Merck KGaA Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Merck KGaA Orally Disintegrating Tablet Excipient Product Portfolio
6.7.5 Merck KGaA Recent Developments/Updates
6.8 Ashland
6.8.1 Ashland Corporation Information
6.8.2 Ashland Description and Business Overview
6.8.3 Ashland Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Ashland Orally Disintegrating Tablet Excipient Product Portfolio
6.8.5 Ashland Recent Developments/Updates
6.9 Meggle Pharma
6.9.1 Meggle Pharma Corporation Information
6.9.2 Meggle Pharma Description and Business Overview
6.9.3 Meggle Pharma Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Meggle Pharma Orally Disintegrating Tablet Excipient Product Portfolio
6.9.5 Meggle Pharma Recent Developments/Updates
6.10 Shin-Etsu
6.10.1 Shin-Etsu Corporation Information
6.10.2 Shin-Etsu Description and Business Overview
6.10.3 Shin-Etsu Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Shin-Etsu Orally Disintegrating Tablet Excipient Product Portfolio
6.10.5 Shin-Etsu Recent Developments/Updates
6.11 Fuji Chemical Industries
6.11.1 Fuji Chemical Industries Corporation Information
6.11.2 Fuji Chemical Industries Orally Disintegrating Tablet Excipient Description and Business Overview
6.11.3 Fuji Chemical Industries Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Fuji Chemical Industries Orally Disintegrating Tablet Excipient Product Portfolio
6.11.5 Fuji Chemical Industries Recent Developments/Updates
6.12 McePharma (Vivesa holding)
6.12.1 McePharma (Vivesa holding) Corporation Information
6.12.2 McePharma (Vivesa holding) Orally Disintegrating Tablet Excipient Description and Business Overview
6.12.3 McePharma (Vivesa holding) Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2019-2024)
6.12.4 McePharma (Vivesa holding) Orally Disintegrating Tablet Excipient Product Portfolio
6.12.5 McePharma (Vivesa holding) Recent Developments/Updates
6.13 Cargill Incorporated
6.13.1 Cargill Incorporated Corporation Information
6.13.2 Cargill Incorporated Orally Disintegrating Tablet Excipient Description and Business Overview
6.13.3 Cargill Incorporated Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Cargill Incorporated Orally Disintegrating Tablet Excipient Product Portfolio
6.13.5 Cargill Incorporated Recent Developments/Updates
6.14 Daicel Corporation
6.14.1 Daicel Corporation Corporation Information
6.14.2 Daicel Corporation Orally Disintegrating Tablet Excipient Description and Business Overview
6.14.3 Daicel Corporation Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Daicel Corporation Orally Disintegrating Tablet Excipient Product Portfolio
6.14.5 Daicel Corporation Recent Developments/Updates
6.15 Anhui Sunhere Pharmaceutical
6.15.1 Anhui Sunhere Pharmaceutical Corporation Information
6.15.2 Anhui Sunhere Pharmaceutical Orally Disintegrating Tablet Excipient Description and Business Overview
6.15.3 Anhui Sunhere Pharmaceutical Orally Disintegrating Tablet Excipient Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Anhui Sunhere Pharmaceutical Orally Disintegrating Tablet Excipient Product Portfolio
6.15.5 Anhui Sunhere Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Orally Disintegrating Tablet Excipient Industry Chain Analysis
7.2 Orally Disintegrating Tablet Excipient Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Orally Disintegrating Tablet Excipient Production Mode & Process
7.4 Orally Disintegrating Tablet Excipient Sales and Marketing
7.4.1 Orally Disintegrating Tablet Excipient Sales Channels
7.4.2 Orally Disintegrating Tablet Excipient Distributors
7.5 Orally Disintegrating Tablet Excipient Customers
8 Orally Disintegrating Tablet Excipient Market Dynamics
8.1 Orally Disintegrating Tablet Excipient Industry Trends
8.2 Orally Disintegrating Tablet Excipient Market Drivers
8.3 Orally Disintegrating Tablet Excipient Market Challenges
8.4 Orally Disintegrating Tablet Excipient Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’